Event Type: The company officials will be attending investor conferences organized by Kotak Institutional Equities, featuring 1x1 meetings and group discussions.
Date and Time: The conferences are scheduled for June 15, 2026 and June 16, 2026, starting at 09:00 AM BST (British Summer Time) onwards.
Location: The events will take place in London, United Kingdom.
Purpose: The discussions during these conferences will be based on publicly available information only.
UPSI Disclosure: The company explicitly states that no unpublished price sensitive information (UPSI) will be discussed during these conferences.
Management Participants: The disclosure mentions "Officials of the Company" but does not specify particular individuals or their designations.
Presentation Materials: The document does not indicate that any presentation, earnings deck, transcript, or recording will be made available.
Additional Notes Section
Regulatory Compliance: This intimation is made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
Website Availability: The intimation is also available on the company's website at www.coronaremedies.com.
Schedule Flexibility: The document notes that changes in the schedule may occur due to exigencies on the part of the host or the company.
Financial Data: No financial data, guidance references, or presentation summaries were disclosed in this announcement.
Attachments: The document does not mention any attachments such as invites, investor decks, conference schedules, or compliance letters.
